Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways
El‐Shaimaa A. Arafa, Wafaa R. Mohamed, Dana M. Zaher, Hany A. Omar
Topics & Concepts
GliclazideUlcerative colitisProinflammatory cytokinePharmacologyMedicineColitisMyeloperoxidaseInflammationMAPK/ERK pathwayInflammatory bowel diseaseDownregulation and upregulationInternal medicineEndocrinologyImmunologySignal transductionChemistryDiabetes mellitusBiochemistryDiseaseGeneInflammatory Bowel DiseaseImmune Response and InflammationNF-κB Signaling Pathways